LSB Industries, Inc. Reports Record Operating Results for the 2022 Fourth Quarter and Full Year
Fourth Quarter 2022 Highlights
- Net sales of
$234 million compared to$190 million in the fourth quarter of 2021 - Adjusted EBITDA(1) of
$105 million compared to$90 million in the fourth quarter of 2021 - Adjusted EPS(1) of
$0.90 compared to$0.72 in the fourth quarter of 2021 - Cash Flow from Operations of
$86 million and Capital Expenditures of$13 million - Repurchased approximately 5.6 million shares during the fourth quarter
Full Year 2022 Highlights
- Net sales of
$902 million compared to$556 million in the full year 2021 - Adjusted EBITDA(1) of
$415 million compared to$191 million in the full year 2021 - Adjusted EPS(1) of
$3.09 compared to$0.85 in the full year 2021 - Cash Flow from Operations of
$346 million and Capital Expenditures of$46 million - Total liquidity of approximately
$460 million as ofDecember 31, 2022 - Successfully completed major turnarounds at two facilities
- Completed
$175 million stock repurchase program of approximately 13.2 million shares during the full year 2022 at an average price of approximately$13 per share leaving shares outstanding as ofDecember 31, 2022 of 76.3 million
“Our fourth quarter capped off the most profitable year in our company's history," stated
“LSB's transformation continued in 2022. In addition to
Fourth Quarter Results Overview
|
|
Three Months Ended |
|
||||||
Product (Gross Sales in |
|
2022 |
|
2021 |
|
% Change |
|
||
AN & Nitric Acid |
|
$ |
81,576 |
|
$ |
74,725 |
|
9 |
% |
Urea ammonium nitrate (UAN) |
|
|
55,449 |
|
|
50,269 |
|
10 |
% |
Ammonia |
|
|
83,144 |
|
|
53,146 |
|
56 |
% |
Other |
|
|
13,485 |
|
|
12,088 |
|
12 |
% |
|
|
$ |
233,654 |
|
$ |
190,228 |
|
23 |
% |
Comparison of 2022 to 2021 quarterly periods:
- Net sales increased during the quarter driven by stronger pricing for all of our products. The benefit of stronger pricing was partially offset by lower sales volumes related to the turnaround at our
Pryor facility and the impact of extremely cold weather that caused theCherokee facility to shut down during the final week of the quarter. - The year-over-year improvement in operating income and adjusted EBITDA primarily resulted from higher selling prices, partially offset by higher natural gas feedstock prices and lower sales volumes.
The following tables provide key sales metrics for our products:
|
|
Three Months Ended |
|
||||||
Key Product Volumes (short tons sold) |
|
2022 |
2021 |
|
% Change |
|
|||
AN & Nitric Acid |
|
|
157,104 |
|
181,467 |
|
(13 |
)% |
|
Urea ammonium nitrate (UAN) |
|
|
102,912 |
|
126,476 |
|
(19 |
)% |
|
Ammonia |
|
|
84,100 |
|
74,801 |
|
12 |
% |
|
|
|
|
344,116 |
|
382,744 |
|
(10 |
)% |
|
Average Selling Prices (price per short ton) (A) |
|
|
|
|
|||||
AN & Nitric Acid |
$ |
464 |
|
$ |
354 |
31 |
% | ||
Urea ammonium nitrate (UAN) |
$ |
522 |
|
$ |
382 |
37 |
% | ||
Ammonia |
$ |
978 |
|
$ |
701 |
40 |
% | ||
|
|
|
|
|
|
|
|
||
(A) Average selling prices represent “net back” prices which are calculated as sales less freight expenses divided by product sales volume in tons. |
|
|
Three Months Ended |
|
||||||
|
|
2022 |
|
2021 |
|
% Change |
|
||
Average Benchmark Prices (price per ton) |
|
|
|
|
|
|
|
||
Tampa Ammonia (MT) Benchmark |
|
$ |
1,116 |
|
$ |
851 |
|
31 |
% |
NOLA UAN |
|
$ |
533 |
|
$ |
530 |
|
1 |
% |
|
|
|
|
|
|
|
|
||
|
|
|
|
|
|
|
|
||
Input Costs |
|
|
|
|
|
|
|
||
Average natural gas cost/MMBtu |
|
$ |
6.95 |
|
$ |
4.42 |
|
57 |
% |
Financial Position and Capital Expenditures
As of
Interest expense for the fourth quarter of 2022 was
During the fourth quarter we repurchased approximately 5.6 million shares of the Company’s stock at an average price of approximately
Capital expenditures were approximately
Market Outlook
Nitrogen fertilizer prices moderated in recent months, largely reflecting a decline in European production costs coupled with the seasonal pause in demand that typically precedes the start of the spring planting season. Despite these factors, nitrogen pricing remains significantly above 10-year averages and appears likely to remain above these averages for 2023 due to the following:
Additionally, natural gas prices in
With respect to industrial markets, demand remains generally stable with domestic end-use markets continuing to be stronger than those in
Sales Volume Outlook
Estimated sales volumes for the full year 2023 are as follows:
Products |
Full Year 2023 |
Full Year Actual |
AN & Nitric Acid |
590,000 – 610,000 |
589,000 |
Urea Ammonium Nitrate (UAN) |
530,000 – 550,000 |
449,000 |
Ammonia |
330,000 – 350,000 |
276,000 |
*2023 sales volumes forecast reflects no planned turnarounds as compared to turnarounds at the |
Conference Call
LSB’s management will host a conference call covering the fourth quarter results on
To listen to a webcast of the call, please go to the Company’s website at www.lsbindustries.com at least 15 minutes prior to the conference call to download and install any necessary audio software. If you are unable to listen live, the conference call webcast will be archived on the Company’s website.
Forward-Looking Statements
Statements in this release that are not historical are forward-looking statements within the meaning of the
Moreover, we operate in a very competitive and rapidly changing environment. New risks and uncertainties emerge from time to time, and it is not possible for our management to predict all risks and uncertainties, nor can management assess the impact of all factors on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements. Although we believe the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, level of activity, performance or achievements. Neither we nor any other person assumes responsibility for the accuracy or completeness of any of these forward-looking statements. You should not rely upon forward-looking statements as predictions of future events. Unless otherwise required by applicable laws, we undertake no obligation to update or revise any forward-looking statements, whether because of new information or future developments.
See Accompanying Tables
Condensed Consolidated Statements of Operations (Unaudited) |
||||||||||||||||
|
|
Three Months Ended |
|
|
Twelve Months Ended |
|
||||||||||
|
|
|
|
|
|
|
||||||||||
|
|
2022 |
|
|
2021 |
|
|
2022 |
|
|
2021 |
|
||||
|
|
(In Thousands, Except Per Share Amounts) |
|
|||||||||||||
Net sales |
|
$ |
233,654 |
|
|
$ |
190,228 |
|
|
$ |
901,711 |
|
|
$ |
556,239 |
|
Cost of sales |
|
|
141,070 |
|
|
|
111,764 |
|
|
|
553,344 |
|
|
|
417,260 |
|
Gross profit |
|
|
92,584 |
|
|
|
78,464 |
|
|
|
348,367 |
|
|
|
138,979 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Selling, general and administrative expense |
|
|
9,717 |
|
|
|
9,090 |
|
|
|
39,428 |
|
|
|
38,028 |
|
Other expense (income), net |
|
|
184 |
|
|
|
(314 |
) |
|
|
561 |
|
|
|
(97 |
) |
Operating income |
|
|
82,683 |
|
|
|
69,688 |
|
|
|
308,378 |
|
|
|
101,048 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Interest expense, net |
|
|
12,372 |
|
|
|
11,760 |
|
|
|
46,827 |
|
|
|
49,378 |
|
Net loss on extinguishments of debt |
|
|
— |
|
|
|
20,259 |
|
|
|
113 |
|
|
|
10,259 |
|
Non-operating other expense (income), net |
|
|
(2,456 |
) |
|
|
(44 |
) |
|
|
(8,083 |
) |
|
|
2,422 |
|
Income before benefit for income taxes |
|
|
72,767 |
|
|
|
37,713 |
|
|
|
269,521 |
|
|
|
38,989 |
|
Provision (benefit) for income taxes |
|
|
6,897 |
|
|
|
(4,369 |
) |
|
|
39,174 |
|
|
|
(4,556 |
) |
Net income |
|
|
65,870 |
|
|
|
42,082 |
|
|
|
230,347 |
|
|
|
43,545 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Dividends on convertible preferred stocks |
|
|
— |
|
|
|
73 |
|
|
|
— |
|
|
|
298 |
|
Dividends on Series E redeemable preferred stock |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
29,914 |
|
Accretion of Series E redeemable preferred stock |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
1,523 |
|
Deemed dividend on Series E and Series F redeemable preferred stocks |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
231,812 |
|
Net income (loss) attributable to common stockholders |
|
$ |
65,870 |
|
|
$ |
42,009 |
|
|
$ |
230,347 |
|
|
$ |
(220,002 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Basic: |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Net income (loss) |
|
$ |
0.84 |
|
|
$ |
0.49 |
|
|
$ |
2.72 |
|
|
$ |
(4.40 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Diluted: |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Net income (loss) |
|
$ |
0.83 |
|
|
$ |
0.47 |
|
|
$ |
2.68 |
|
|
$ |
(4.40 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Adjusted Net Income and Adjusted EPS(1) |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Adjusted net income attributable to common stockholders, excluding Exchange Transaction |
|
$ |
65,870 |
|
|
$ |
42,009 |
|
|
$ |
230,347 |
|
|
$ |
43,247 |
|
Other adjustments |
|
|
5,698 |
|
|
|
23,005 |
|
|
|
35,706 |
|
|
|
32,721 |
|
Adjusted net income attributable to common stockholders, excluding Exchange Transaction and other adjustments |
|
$ |
71,568 |
|
|
$ |
65,014 |
|
|
$ |
266,053 |
|
|
$ |
75,968 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Adjusted net income per common share, excluding Exchange Transaction and other adjustments |
|
$ |
0.90 |
|
|
$ |
0.72 |
|
|
$ |
3.09 |
|
|
$ |
0.85 |
|
(1) This is a Non-GAAP measure. Refer to the Non-GAAP Reconciliation section. |
Consolidated Balance Sheets (Information at |
||||||||
|
|
|
|
|||||
|
|
2022 |
|
|
2021 |
|
||
|
|
(In Thousands) |
|
|||||
Assets |
|
|
|
|
|
|
||
Current assets: |
|
|
|
|
|
|
||
Cash and cash equivalents |
|
$ |
63,769 |
|
|
$ |
82,144 |
|
Short-term investments |
|
|
330,553 |
|
|
|
— |
|
Accounts receivable |
|
|
75,494 |
|
|
|
86,902 |
|
Allowance for doubtful accounts |
|
|
(699 |
) |
|
|
(474 |
) |
Accounts receivable, net |
|
|
74,795 |
|
|
|
86,428 |
|
Inventories: |
|
|
|
|
|
|
||
Finished goods |
|
|
28,893 |
|
|
|
14,688 |
|
Raw materials |
|
|
1,990 |
|
|
|
1,895 |
|
Total inventories |
|
|
30,883 |
|
|
|
16,583 |
|
Supplies, prepaid items and other: |
|
|
|
|
|
|
||
Prepaid insurance |
|
|
17,429 |
|
|
|
14,244 |
|
Precious metals |
|
|
13,323 |
|
|
|
14,945 |
|
Supplies |
|
|
27,501 |
|
|
|
26,558 |
|
Other |
|
|
8,346 |
|
|
|
2,234 |
|
Total supplies, prepaid items and other |
|
|
66,599 |
|
|
|
57,981 |
|
Total current assets |
|
|
566,599 |
|
|
|
243,136 |
|
|
|
|
|
|
|
|
||
Property, plant and equipment, net |
|
|
848,661 |
|
|
|
858,480 |
|
|
|
|
|
|
|
|
||
Other assets: |
|
|
|
|
|
|
||
Operating lease assets |
|
|
22,682 |
|
|
|
27,317 |
|
Intangible and other assets, net |
|
|
1,877 |
|
|
|
3,907 |
|
|
|
|
24,559 |
|
|
|
31,224 |
|
|
|
$ |
1,439,819 |
|
|
$ |
1,132,840 |
|
Consolidated Balance Sheets (continued) (Information at |
||||||||
|
|
|
|
|||||
|
|
2022 |
|
|
2021 |
|
||
|
|
(In Thousands) |
|
|||||
Liabilities and Stockholders' Equity |
|
|
|
|
|
|
||
Current liabilities: |
|
|
|
|
|
|
||
Accounts payable |
|
$ |
78,182 |
|
|
$ |
49,458 |
|
Short-term financing |
|
|
16,134 |
|
|
|
12,716 |
|
Accrued and other liabilities |
|
|
38,470 |
|
|
|
33,301 |
|
Current portion of long-term debt |
|
|
9,522 |
|
|
|
9,454 |
|
Total current liabilities |
|
|
142,308 |
|
|
|
104,929 |
|
|
|
|
|
|
|
|
||
Long-term debt, net |
|
|
702,733 |
|
|
|
518,190 |
|
|
|
|
|
|
|
|
||
Noncurrent operating lease liabilities |
|
|
14,896 |
|
|
|
19,568 |
|
|
|
|
|
|
|
|
||
Other noncurrent accrued and other liabilities |
|
|
522 |
|
|
|
3,030 |
|
|
|
|
|
|
|
|
||
Deferred income taxes |
|
|
63,487 |
|
|
|
26,633 |
|
|
|
|
|
|
|
|
||
Commitments and contingencies |
|
|
|
|
|
|
||
|
|
|
|
|
|
|
||
Stockholders' equity: |
|
|
|
|
|
|
||
Common stock, |
|
|
9,117 |
|
|
|
9,117 |
|
Capital in excess of par value |
|
|
497,179 |
|
|
|
493,161 |
|
Retained earnings (accumulated deficit) |
|
|
199,092 |
|
|
|
(31,255 |
) |
|
|
|
705,388 |
|
|
|
471,023 |
|
Less treasury stock, at cost: |
|
|
|
|
|
|
||
Common stock, 14.9 million shares (1.4 million shares at |
|
|
189,515 |
|
|
|
10,533 |
|
Total stockholders' equity |
|
|
515,873 |
|
|
|
460,490 |
|
|
|
$ |
1,439,819 |
|
|
$ |
1,132,840 |
|
Non-GAAP Reconciliations
This news release includes certain “non-GAAP financial measures” under the rules of the
EBITDA and Adjusted EBITDA Reconciliation
EBITDA is defined as net income (loss) plus interest expense, less gain on extinguishment of debt, plus depreciation and amortization (D&A) (which includes D&A of property, plant and equipment and amortization of intangible and other assets), plus provision (benefit) for income taxes. Adjusted EBITDA is reported to show the impact of non-cash stock-based compensation, one time/non-cash or non-operating items-such as, one-time income or fees, loss (gain) on sale of a business and/or other property and equipment, certain fair market value (FMV) adjustments, and consulting costs associated with reliability and purchasing initiatives (Initiatives). We historically have performed turnaround activities on an annual basis; however, we have moved towards extending turnarounds to a two or three-year cycle. Rather than being capitalized and amortized over the period of benefit, our accounting policy is to recognize the costs as incurred. Given these turnarounds are essentially investments that provide benefits over multiple years, they are not reflective of our operating performance in a given year.
We believe that certain investors consider EBITDA a useful means of measuring our ability to meet our debt service obligations and evaluating our financial performance. In addition, we believe that certain investors consider adjusted EBITDA as more meaningful to further assess our performance. We believe that the inclusion of supplementary adjustments to EBITDA is appropriate to provide additional information to investors about certain items.
EBITDA and adjusted EBITDA have limitations and should not be considered in isolation or as a substitute for net income, operating income, cash flow from operations or other consolidated income or cash flow data prepared in accordance with GAAP. Because not all companies use identical calculations, this presentation of EBITDA and adjusted EBITDA may not be comparable to a similarly titled measure of other companies. The following table provides a reconciliation of net income (loss) to EBITDA and adjusted EBITDA for the periods indicated. Adjusted EBITDA margin is calculated by taking adjusted EBITDA divided by
Adjusted Net Income (Loss) and Adjusted Net Income (Loss) Per Share
Adjusted Net Income (Loss) and Adjusted Net Income (Loss) per share have been adjusted for the impact of the closing of the Exchange Transaction on
Non-GAAP Reconciliations (continued) |
|||||||||||||
LSB Consolidated ($ In Thousands) |
|
Three Months Ended |
|
Year Ended |
|
||||||||
|
|
2022 |
|
2021 |
|
2022 |
|
2021 |
|
||||
Net income |
|
$ |
65,870 |
|
$ |
42,082 |
|
$ |
230,347 |
|
$ |
43,545 |
|
Plus: |
|
|
|
|
|
|
|
|
|
||||
Interest expense, net |
|
|
9,908 |
|
|
11,760 |
|
|
41,407 |
|
|
49,378 |
|
Net loss on extinguishments of debt |
|
- |
|
|
20,259 |
|
|
113 |
|
|
10,259 |
|
|
Depreciation and amortization |
|
|
17,117 |
|
|
17,619 |
|
|
68,019 |
|
|
69,943 |
|
Provision (benefit) for income taxes |
|
|
6,897 |
|
|
(4,369 |
) |
|
39,174 |
|
|
(4,556 |
) |
EBITDA |
|
$ |
99,792 |
|
$ |
87,351 |
|
$ |
379,060 |
|
$ |
168,569 |
|
|
|
|
|
|
|
|
|
|
|
||||
Stock-based compensation |
|
|
936 |
|
|
1,187 |
|
|
4,025 |
|
|
5,516 |
|
Change of Control |
|
- |
|
- |
|
- |
|
|
3,223 |
|
|||
Noncash (gain) on natural gas contracts |
|
- |
|
- |
|
- |
|
|
(1,205 |
) |
|||
Legal fees (Leidos) |
|
|
200 |
|
|
296 |
|
|
1,114 |
|
|
1,894 |
|
Loss on disposal of assets |
|
|
391 |
|
|
133 |
|
|
1,219 |
|
|
823 |
|
Fair market value adjustment on preferred stock embedded derivatives |
|
- |
|
- |
|
- |
|
|
2,258 |
|
|||
Turnaround costs |
|
|
4,171 |
|
|
1,130 |
|
|
29,235 |
|
|
9,953 |
|
Adjusted EBITDA |
|
$ |
105,490 |
|
$ |
90,097 |
|
$ |
414,653 |
|
$ |
191,031 |
|
Non-GAAP Reconciliations (continued) (in thousands, except per share amounts) |
|||||||||||||
|
|
Three Months Ended |
|
Twelve Months Ended |
|
||||||||
|
|
|
|
|
|
||||||||
|
|
2022 |
|
2021 |
|
2022 |
|
2021 |
|
||||
Numerator: |
|
|
|
|
|
|
|
|
|
||||
Net income (loss) attributable to common stockholders |
|
$ |
65,870 |
|
$ |
42,009 |
|
$ |
230,347 |
|
$ |
(220,002 |
) |
Adjustments for Exchange Transaction: |
|
|
|
|
|
|
|
|
|
||||
Dividend requirements on Series E Redeemable Preferred |
|
|
- |
|
|
- |
|
|
- |
|
|
29,914 |
|
Deemed dividend on Series E and Series F Redeemable Preferred |
|
|
- |
|
|
- |
|
|
- |
|
|
231,812 |
|
Accretion of Series E Redeemable Preferred |
|
|
- |
|
|
- |
|
|
- |
|
|
1,523 |
|
Adjusted net income attributable to common stockholders, excluding Exchange Transaction |
|
|
65,870 |
|
|
42,009 |
|
|
230,347 |
|
|
43,247 |
|
Other Adjustments: |
|
|
|
|
|
|
|
|
|
||||
Stock-based compensation |
|
|
936 |
|
|
1,187 |
|
|
4,025 |
|
|
5,516 |
|
Change of control |
|
|
- |
|
|
- |
|
|
- |
|
|
3,223 |
|
Noncash gain on natural gas contracts |
|
|
- |
|
|
- |
|
|
- |
|
|
(1,205 |
) |
Legal fees (Leidos) |
|
|
200 |
|
|
296 |
|
|
1,114 |
|
|
1,894 |
|
Loss on disposal of assets |
|
|
391 |
|
|
133 |
|
|
1,219 |
|
|
823 |
|
FMV adjustment on preferred stock embedded derivative |
|
|
- |
|
|
- |
|
|
- |
|
|
2,258 |
|
Turnaround costs |
|
|
4,171 |
|
|
1,130 |
|
|
29,235 |
|
|
9,953 |
|
Net loss on extinguishment of debt |
|
|
- |
|
|
20,259 |
|
|
113 |
|
|
10,259 |
|
Adjusted net income attributable to common stockholders, excluding Exchange Transaction and other adjustments |
|
$ |
71,568 |
|
$ |
65,014 |
|
$ |
266,053 |
|
$ |
75,968 |
|
Denominator: |
|
|
|
|
|
|
|
|
|
||||
Adjusted weighted-average shares for basic net income per share and for adjusted net income per share, excluding Exchange Transaction (1) |
|
|
78,224 |
|
|
86,507 |
|
|
84,753 |
|
|
49,963 |
|
Adjustment: |
|
|
|
|
|
|
|
|
|
||||
Unweighted shares, including unvested restricted stock subject to forfeiture |
|
|
859 |
|
|
3,286 |
|
|
1,250 |
|
|
39,830 |
|
Outstanding shares, net of treasury, at period end for adjusted net income per share, excluding Exchange Transaction and other adjustments |
|
|
79,083 |
|
|
89,793 |
|
|
86,003 |
|
|
89,793 |
|
|
|
|
|
|
|
|
|
|
|
||||
Basic net income (loss) per common share |
|
$ |
0.84 |
|
$ |
0.49 |
|
$ |
2.72 |
|
$ |
(4.40 |
) |
|
|
|
|
|
|
|
|
|
|
||||
Adjusted net income per common share, excluding Exchange Transaction |
|
$ |
0.84 |
|
$ |
0.49 |
|
$ |
2.72 |
|
$ |
0.87 |
|
|
|
|
|
|
|
|
|
|
|
||||
Adjusted net income per common share, excluding Exchange Transaction and other adjustments |
|
$ |
0.90 |
|
$ |
0.72 |
|
$ |
3.09 |
|
$ |
0.85 |
|
|
|
|
|
|
|
|
|
|
|
||||
|
|
|
|
|
|
|
|
|
|
||||
Adjusted Net Income and Adjusted EPS(1) |
|
|
|
|
|
|
|
|
|
||||
Adjusted net income attributable to common stockholders, excluding Exchange Transaction |
|
$ |
65,870 |
|
$ |
42,009 |
|
$ |
230,347 |
|
$ |
43,247 |
|
Other adjustments |
|
|
5,698 |
|
|
23,005 |
|
|
35,706 |
|
|
32,721 |
|
Adjusted net income |
|
$ |
71,568 |
|
$ |
65,014 |
|
$ |
266,053 |
|
$ |
75,968 |
|
|
|
|
|
|
|
|
|
|
|
||||
Adjusted net income per common share, excluding Exchange Transaction and other adjustments |
|
$ |
0.90 |
|
$ |
0.72 |
|
$ |
3.09 |
|
$ |
0.85 |
|
(1) Excludes the weighted-average shares of unvested restricted stock that are subject to forfeiture |
Ammonia, AN, Nitric Acid, UAN Sales Price Reconciliation
The following table provides a reconciliation of total identified net sales as reported under GAAP in our consolidated financial statements reconciled to netback sales which is calculated as net sales less freight and other non-netback costs. We believe this provides a relevant industry comparison among our peer group.
|
|
Three Months Ended |
||||
|
|
2022 |
|
2021 |
||
|
|
(In Thousands) |
||||
Ammonia, AN, Nitric Acid, UAN Net sales |
|
$ |
220,170 |
|
$ |
178,140 |
|
|
|
|
|
||
Less freight and other |
|
|
11,344 |
|
|
13,233 |
|
|
|
|
|
||
Ammonia, AN, Nitric Acid, UAN netback sales |
|
$ |
208,826 |
|
$ |
164,907 |
View source version on businesswire.com: https://www.businesswire.com/news/home/20230222005947/en/
(405) 510-3524
(405) 510-3550
fbuonocore@lsbindustries.com
Source: